CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1475-2867
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis ; volume:21 ; number:1 ; day:4 ; month:12 ; year:2021 ; pages:1-16 ; date:12.2021
Cancer cell international ; 21, Heft 1 (4.12.2021), 1-16, 12.2021

Urheber
Kong, Haoran
Yu, Wenhui
Chen, Zhuning
Li, Haonan
Ye, Guiwen
Hong, Jiacong
Xie, Zhongyu
Chen, Keng
Wu, Yanfeng
Shen, Huiyong
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12935-021-02320-0
URN
urn:nbn:de:101:1-2022020719422103514601
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:35 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Kong, Haoran
  • Yu, Wenhui
  • Chen, Zhuning
  • Li, Haonan
  • Ye, Guiwen
  • Hong, Jiacong
  • Xie, Zhongyu
  • Chen, Keng
  • Wu, Yanfeng
  • Shen, Huiyong
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Correction to: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

Correction to: CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis

Toosendanin inhibits adipogenesis by activating Wnt/β-catenin signaling

Toosendanin inhibits adipogenesis by activating Wnt/β-catenin signaling

NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling

NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling

LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation

LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation

TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling

TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/β-catenin signaling

FOXH1 promotes lung cancer progression by activating the Wnt/β-catenin signaling pathway

FOXH1 promotes lung cancer progression by activating the Wnt/β-catenin signaling pathway

AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling

AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway

Retraction Note: Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway

Retraction Note: Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway

UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway

UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway

MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway

MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway

Verbundene Objekte